Next Article in Journal
Synthesis and Biological Evaluation of Azamacrolide Comprising the Triazole Moiety as Quorum Sensing Inhibitors
Previous Article in Journal
Syzygium Cordatum Hochst. ex Krauss: An Overview of Its Ethnobotany, Phytochemistry and Pharmacological Properties
Previous Article in Special Issue
Liposomal Formulations for an Efficient Encapsulation of Epigallocatechin-3-Gallate: An In-Silico/Experimental Approach
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessFeature PaperCommunication
Molecules 2018, 23(5), 1085;

Liposomes as Gene Delivery Vectors for Human Placental Cells

Chimie ParisTech, PSL Research University, University de Technologies Chimiques et Biologiques pour la Santé (UTCBS), F-75005 Paris, France
CNRS, UTCBS UMR 8258, F-75006 Paris, France
Paris Descartes University, Sorbonne-Paris-Cité, F-75006 Paris, France
INSERM, UTCBS U 1022, F-75006 Paris, France
INSERM, UMR-S1139, Faculty of pharmacy, F-75006 Paris, France
Laboratoire de Vectorisation Génétique, Faculty of pharmacy, Montreal University, Montreal, QC H3C 3J7, Canada
Foundation PremUp, F-75006 Paris, France
Author to whom correspondence should be addressed.
Academic Editor: Sophia G. Antimisiaris
Received: 29 March 2018 / Revised: 20 April 2018 / Accepted: 30 April 2018 / Published: 4 May 2018
(This article belongs to the Special Issue Liposomes as Drug Carriers)
Full-Text   |   PDF [1414 KB, uploaded 4 May 2018]   |  


Nanomedicine as a therapeutic approach for pregnancy-related diseases could offer improved treatments for the mother while avoiding side effects for the fetus. In this study, we evaluated the potential of liposomes as carriers for small interfering RNAs to placental cells. Three neutral formulations carrying rhodamine-labelled siRNAs were evaluated on an in vitro model, i.e., human primary villous cytotrophoblasts. siRNA internalization rate from lipoplexes were compared to the one in the presence of the lipofectamine reagent and assessed by confocal microscopy. Results showed cellular internalization of nucleic acid with all three formulations, based on two cationic lipids, either DMAPAP or CSL-3. Moreover, incubation with DMAPAP+AA provided a rate of labelled cells as high as with lipofectamine (53 ± 15% and 44 ± 12%, respectively) while being more biocompatible. The proportion of cells which internalized siRNA were similar when using DMAPAP/DDSTU (16 ± 5%) and CSL-3 (22 ± 5%). This work highlights that liposomes could be a promising approach for gene therapy dedicated to pregnant patients. View Full-Text
Keywords: liposomes; siRNA; placenta; primary trophoblast cells liposomes; siRNA; placenta; primary trophoblast cells

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Valero, L.; Alhareth, K.; Espinoza Romero, J.; Viricel, W.; Leblond, J.; Chissey, A.; Dhotel, H.; Roques, C.; Campiol Arruda, D.; Escriou, V.; Mignet, N.; Fournier, T.; Andrieux, K. Liposomes as Gene Delivery Vectors for Human Placental Cells. Molecules 2018, 23, 1085.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top